Search research articles
Contact Us
Filters
Showing results (171-180 of 4,797) with videos related to
Page
of 480
Sort By:
European Journal of Heart Failure
|
February 2, 2018
Are physicians neglecting the risk of heart failure in diabetic patients who are receiving sulfonylureas? Lessons from the TOSCA.IT trial
Milton Packer
Cardiovascular Research
|
April 4, 2020
Critical examination of mechanisms underlying the reduction in heart failure events with SGLT2 inhibitors: identification of a molecular link between their actions to stimulate erythrocytosis and to alleviate cellular stress
Milton Packer
European Heart Journal
|
May 24, 2019
Are healthcare systems now ready to adopt sacubitril/valsartan as the preferred approach to inhibiting the renin-angiotensin system in chronic heart failure? The culmination of a 20-year journey
Milton Packer
Journal of Cardiovascular Electrophysiology
|
October 19, 2019
Heightened risk of intensive rate control in patients with atrial fibrillation who are obese or have type 2 diabetes: A critical review and re-evaluation
Milton Packer
Diabetes, Obesity & Metabolism
|
May 31, 2019
Critical role of the epicardium in mediating cardiac inflammation and fibrosis in patients with type 2 diabetes
Milton Packer
American Practitioner and Digest of Treatment
|
March 19, 2010
New knowledge in the treatment of malaria
H PACKER
Journal of Cardiac Failure
|
April 19, 2023
The First Dedicated Comprehensive Heart Failure Program in the United States: The Division of Circulatory Physiology at Columbia Presbyterian (1992-2004)
Milton Packer
Nature
|
August 10, 2012
Science for the masses: Time for a Higgs metaphor upgrade
Charles Packer
Circulation
|
January 1, 1989
Therapeutic options in the management of chronic heart failure. Is there a drug of first choice?
M Packer
The New England Journal of Medicine
|
March 16, 1989
Drug therapy. Combined beta-adrenergic and calcium-entry blockade in angina pectoris
M Packer
Page
of 480
Search research articles
Search
Showing results (171-180 of 4,797) with videos related to
Sort By:
Page
of 480
European Journal of Heart Failure
|
February 2, 2018
Are physicians neglecting the risk of heart failure in diabetic patients who are receiving sulfonylureas? Lessons from the TOSCA.IT trial
Milton Packer
Cardiovascular Research
|
April 4, 2020
Critical examination of mechanisms underlying the reduction in heart failure events with SGLT2 inhibitors: identification of a molecular link between their actions to stimulate erythrocytosis and to alleviate cellular stress
Milton Packer
European Heart Journal
|
May 24, 2019
Are healthcare systems now ready to adopt sacubitril/valsartan as the preferred approach to inhibiting the renin-angiotensin system in chronic heart failure? The culmination of a 20-year journey
Milton Packer
Journal of Cardiovascular Electrophysiology
|
October 19, 2019
Heightened risk of intensive rate control in patients with atrial fibrillation who are obese or have type 2 diabetes: A critical review and re-evaluation
Milton Packer
Diabetes, Obesity & Metabolism
|
May 31, 2019
Critical role of the epicardium in mediating cardiac inflammation and fibrosis in patients with type 2 diabetes
Milton Packer
American Practitioner and Digest of Treatment
|
March 19, 2010
New knowledge in the treatment of malaria
H PACKER
Journal of Cardiac Failure
|
April 19, 2023
The First Dedicated Comprehensive Heart Failure Program in the United States: The Division of Circulatory Physiology at Columbia Presbyterian (1992-2004)
Milton Packer
Nature
|
August 10, 2012
Science for the masses: Time for a Higgs metaphor upgrade
Charles Packer
Circulation
|
January 1, 1989
Therapeutic options in the management of chronic heart failure. Is there a drug of first choice?
M Packer
The New England Journal of Medicine
|
March 16, 1989
Drug therapy. Combined beta-adrenergic and calcium-entry blockade in angina pectoris
M Packer
Page
of 480